How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a ...

Chronic inflammation, seen in Crohn’s disease and ulcerative colitis, can suppress a group of enzymes called CYP450. Some medicines are metabolized by these enzymes.

Guselkumab, a medication with a mechanism of action that is new to inflammatory bowel disease (IBD) treatment, outperformed ...

A new Crohn’s treatment that involves guselkumab showed outstandingly greater rates of endoscopic improvement, which are vital for reducing long-term complications.

Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately ...

A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...

Crohn’s is an autoimmune disorder that causes inflammation and damage to the gastrointestinal (GI) tract, according to the U.S. Centers for Disease Control and Prevention. Crohn’s disease may ...

The severity of Crohn's-related joint symptoms often mirrors the severity of intestinal symptoms, but not always. Learn more about the link between Crohn's disease and arthritis and how to manage it.

Crohn’s Disease can lead to complications beyond the gut, such as skin problems, joint pain, and bowel obstruction. There is no single cause, but it is believed to be triggered by a mix of ...

Crohn’s disease isn’t just about digestion. ... While older approaches relied heavily on steroids and broad-spectrum immunosuppressants, modern medicine now offers more targeted therapies.

Health and Medicine; Targeted mRNA Therapy Holds Promise for Crohn’s Disease, Colitis, and Beyond. By. Pesach Benson / TPS - 29 Tevet 5785 – January 29, 2025. 0. Share on Facebook.

IgG-seq identifies enteric bacteria recognized by serum IgG. Credit: Gut Microbes (2025). DOI: 10.1080/19490976.2025.2464221 ...